lydicamycin

lydicamycin Structure
CAS No.
133352-27-9
Chemical Name:
lydicamycin
Synonyms
lydicamycin;1-Pyrrolidinecarboximidamide, 2-[21-[1-[(2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)carbonyl]-1,2,4a,5,6,7,8,8a-octahydro-5,6-dihydroxy-1,3-dimethyl-2-naphthalenyl]-2,6,10,14,18-pentahydroxy-5,11,17,19-tetramethyl-4,8,12,16-heneicosatetraen-1-yl]-
CBNumber:
CB61361973
Molecular Formula:
C47H74N4O10
Molecular Weight:
855.12
MOL File:
133352-27-9.mol
MSDS File:
SDS
Modify Date:
2023/5/21 10:59:17

lydicamycin Properties

Density 1.30±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
form Colorless film.
pka 4.50±1.00(Predicted)

lydicamycin Chemical Properties,Uses,Production

Uses

Lydicamycin belongs to a novel structural class with highly selective antibiotic activity. Recent research has shown that lydicamycin and the related metabolites, TPU-0037-A and TPU-0037-C, are highly active against MRSA. Lydicamycin is also closely related to BN 4515N which was isolated from a strain of Microtetraspora as a neuritogenic agent.

lydicamycin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 43)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
BOC Sciences 16314854226; +16314854226 United States 19743 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd +86-19164747840 +86-13119157289 China 2969 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 52927 58 Inquiry
Shanghai Moqi Biological Technology Co., LTD 021-38218169 13341702378 China 9117 58 Inquiry
TargetMol Chemicals Inc. 15002134094 China 28118 58 Inquiry
Cayman Chemical Company (800) 364-9897 United States 6618 81 Inquiry
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 China 9708 58 Inquiry
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 13028896684 China 56057 58 Inquiry
Tebu-bio France 251 75 Inquiry
lydicamycin 1-Pyrrolidinecarboximidamide, 2-[21-[1-[(2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)carbonyl]-1,2,4a,5,6,7,8,8a-octahydro-5,6-dihydroxy-1,3-dimethyl-2-naphthalenyl]-2,6,10,14,18-pentahydroxy-5,11,17,19-tetramethyl-4,8,12,16-heneicosatetraen-1-yl]- 133352-27-9 C47H74N4O10